Sarepta Therapeutics
SRPT
#1452
Rank
โ‚ฌ11.05 B
Marketcap
115,93ย โ‚ฌ
Share price
2.76%
Change (1 day)
4.91%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ2.11 B

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ2.11 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ2.17 B-14.93%
2022-12-31โ‚ฌ2.55 B31.07%
2021-12-31โ‚ฌ1.95 B7.3%
2020-12-31โ‚ฌ1.81 B103.25%
2019-12-31โ‚ฌ0.89 B68.08%
2018-12-31โ‚ฌ0.53 B23.13%
2017-12-31โ‚ฌ0.43 B420.24%
2016-12-31โ‚ฌ83.1 M8.74%
2015-12-31โ‚ฌ76.42 M96.36%
2014-12-31โ‚ฌ38.92 M21.17%
2013-12-31โ‚ฌ32.12 M-47.79%
2012-12-31โ‚ฌ61.52 M242.15%
2011-12-31โ‚ฌ17.98 M-51.11%
2010-12-31โ‚ฌ36.77 M44.65%
2009-12-31โ‚ฌ25.42 M265.86%
2008-12-31โ‚ฌ6.94 M-16.41%
2007-12-31โ‚ฌ8.31 M248.14%
2006-12-31โ‚ฌ2.38 M2.94%
2005-12-31โ‚ฌ2.31 M55.91%
2004-12-31โ‚ฌ1.48 M-50.45%
2003-12-31โ‚ฌ3 M-38.72%
2002-12-31โ‚ฌ4.89 M31.89%
2001-12-31โ‚ฌ3.71 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ31.92 B 1,407.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.03 B-4.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.11 B-94.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.85 B-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.62 B 70.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.61 B 23.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.59 B-24.54%๐Ÿ‡บ๐Ÿ‡ธ USA